2 months Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of “Moderate Buy” by Analysts MarketBeat
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been given an average rating of “Moderate Buy” by the nine research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rate…
Nasdaq 100 · Pharmaceuticals · Science
X